NEWCaplight raises a $16M Series A, led by BlackRock and Fin Capital →
Skip to main content
Caplight Logo









Terns Pharmaceutical

Terns Pharmaceutical

Public
Foster City, CaliforniaBiotechhttps://www.ternspharma.com

Terns Pharmaceutical is now publicly traded

The data on this page reflects Terns Pharmaceutical's private-market history up to the point it went public, including its funding rounds, valuation, and investors.

Went Public

Feb 10, 2021

Last Round

Follow-on Offering

Dec 11, 2025

Total Funding Raised

$1.26B

Company Overview

Terns Pharmaceuticals (NAS: TERN) is a biopharmaceutical company focused on developing small-molecule therapies for non-alcoholic steatohepatitis (NASH) and other chronic liver diseases.

Sector

Biotech

AI Layer

Non-AI

Keywords

allosteric BCR-ABL tyrosine kinase inhibitorsmall-molecule drug developmentchronic myeloid leukemia (CML) therapyoncology drug pipelineoral GLP-1 receptor agonist for obesitymetabolic disease therapeuticsABL myristoyl pocket inhibitorTHR-β agonist for MASHGIPR modulators for obesitybiopharma drug licensing modelclinical-stage biopharmaceutical company

Terns Pharmaceutical Comparables

Compare Terns Pharmaceutical with similar companies based on industry and business-model similarity.

Terns Pharmaceutical comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Eccogene
74%
Rivus Pharmaceuticals
70%
Anfibrosia
66%

Terns Pharmaceutical Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Follow-on OfferingDec 11, 2025
Follow-on OfferingSep 12, 2024
IPOFeb 10, 2021
Series CJan 5, 2021
Series BOct 30, 2018
Series A
Apr 4, 2018

Terns Pharmaceutical Investors

Notable investors and investment history

Terns Pharmaceutical investors
InvestorRounds
JefferiesFollow-on Offering
Deerfield ManagementSeries C
Suvretta Capital ManagementSeries C
OrbiMedSeries C, Series B
TD CowenFollow-on Offering
Goldman Sachs Group, Inc.IPO
UBS Investment BankFollow-on Offering

Terns Pharmaceutical Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Terns Pharmaceutical Filings

SEC and related filings with document metadata.

Firmographic Details

HeadquartersFoster City, California
Employee Range66
Year Founded2017
Last FundingDec 11, 2025

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.